The team, led by Professor Michael Desai, found that diseases can evolve by "bet-hedging," a strategy in which a population of organisms invests in multiple different strategies to increase its chances of survival in uncertain environments.
In the case of bacteria, bet-hedging can involve producing different types of proteins, such as enzymes or toxins, that can help them survive in different conditions. This can make it more difficult for antibiotics to target and kill all of the bacteria, leading to the evolution of antibiotic resistance.
The researchers believe that bet-hedging could be a common mechanism of evolution for a wide variety of diseases, and could help explain why some diseases are so difficult to treat and eradicate. The discovery could also lead to new strategies for developing drugs and treatments that are more effective at combating diseases that evolve through bet-hedging.
"Our findings suggest that bet-hedging may be a fundamental evolutionary strategy that contributes to the emergence and persistence of diverse diseases," the researchers wrote in their study, which was published in the journal Nature Microbiology.
The researchers used computer models and laboratory experiments with yeast and bacteria to study how bet-hedging affects disease evolution. They found that bet-hedging can lead to the evolution of more diverse populations of pathogens, which can make it more difficult for antibiotics to target and kill all of the pathogens.
"This means that bet-hedging could be a key factor in the evolution of antibiotic resistance and other diseases that are difficult to treat," said Desai.
The researchers also found that bet-hedging can help diseases to survive and spread in fluctuating environments, such as the human body. This could help explain why some diseases, such as the flu, are seasonal and tend to spread more during certain times of the year.
"Bet-hedging could be a way for diseases to adapt to changing environments, which could help them to survive and spread more effectively," said Desai.
The researchers believe that their findings could lead to new strategies for developing drugs and treatments that are more effective at combating diseases that evolve through bet-hedging. For example, drugs could be designed to target multiple different strategies that a disease uses to bet-hedge, making it more difficult for the disease to evolve resistance.
"Our findings could have important implications for the development of new therapies to treat a variety of diseases," said Desai. "By understanding how diseases evolve through bet-hedging, we may be able to develop more effective drugs and treatments that can help to improve human health."
